rs565918031
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The NM_001458.5(FLNC):c.4651G>A(p.Ala1551Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000215 in 1,613,602 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001458.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLNC | NM_001458.5 | c.4651G>A | p.Ala1551Thr | missense_variant | 27/48 | ENST00000325888.13 | NP_001449.3 | |
FLNC | NM_001127487.2 | c.4651G>A | p.Ala1551Thr | missense_variant | 27/47 | NP_001120959.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLNC | ENST00000325888.13 | c.4651G>A | p.Ala1551Thr | missense_variant | 27/48 | 1 | NM_001458.5 | ENSP00000327145.8 | ||
FLNC | ENST00000346177.6 | c.4651G>A | p.Ala1551Thr | missense_variant | 27/47 | 1 | ENSP00000344002.6 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000125 AC: 31AN: 248786Hom.: 0 AF XY: 0.0000962 AC XY: 13AN XY: 135074
GnomAD4 exome AF: 0.000228 AC: 333AN: 1461278Hom.: 1 Cov.: 34 AF XY: 0.000217 AC XY: 158AN XY: 726990
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152324Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74488
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 24, 2021 | Identified in association with frontotemporal dementia (Janssens et al., 2015) and hypertrophic cardiomyopathy (Jaafar et al., 2016) in published literature; Reported as a variant of uncertain significance by another clinical laboratory in ClinVar (ClinVar Variant ID# 539435; Landrum et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26555887, 27574918, 32936277) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 26, 2022 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2022 | The p.A1551T variant (also known as c.4651G>A), located in coding exon 27 of the FLNC gene, results from a G to A substitution at nucleotide position 4651. The alanine at codon 1551 is replaced by threonine, an amino acid with similar properties. This variant has been detected in an individual with hypertrophic cardiomyopathy, and has also been detected in an individual with frontotemporal dementia (Janssens J et al. Acta Neuropathol Commun, 2015;3:68; Jaafar N et al. Genet Test Mol Biomarkers. 2016;20:674-679). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 14, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at